General Information of Drug Transporter (DT)
DT ID DTD0330 Transporter Info
Gene Name SLC38A3
Transporter Name Sodium-coupled neutral amino acid transporter 3
Gene ID
10991
UniProt ID
Q99624
Post-Translational Modification of This DT
Overview of SLC38A3 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

74

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A3 Asparagine 74 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

247

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A3 Asparagine 247 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

248

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A3 Asparagine 248 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

252

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A3 Asparagine 252 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

323

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A3 Asparagine 323 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A3 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

368

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC38A3 Cystine 368 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A3 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

19

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Serine 19 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A3 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

47

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Serine 47 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A3 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

52

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Serine 52 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A3 [6] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

54

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Serine 54 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A3 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

120

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Serine 120 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC38A3 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

121

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Serine 121 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A3 [6] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

60

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Threonine 60 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A3 [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

129

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A3 Tyrosine 129 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A3 [11]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

46

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A3 Lysine 46 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A3 [11]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

51

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A3 Lysine 51 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A3 [11]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

55

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A3 Lysine 55 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S38A3_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
4 Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
5 Adaptation of HepG2 cells to a steady-state reduction in the content of protein phosphatase 6 (PP6) catalytic subunit. Exp Cell Res. 2015 Jul 15;335(2):224-37.
6 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
7 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
8 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
9 Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
10 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
11 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.